Atossa amends IPO

Atossa Genetics Inc. (Seattle, Wash.) amended its IPO and now hopes to sell 1.2 million shares at $4-$6 in an offering underwritten by Dawson James Securities on NASDAQ. If sold in full at the midpoint of $5, Atossa would raise $6 million and be valued at $62.3 million. In February, the company filed proposed to sell up to 1 million shares at $5-$7. At the $6 mid-point of the original range and 1 million shares, Atossa would have raised $6 million and been valued at $73.5 million. This is Atossa's third IPO filing; the company previously withdrew filings in 2010 and 2011, the most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex (see BioCentury Extra, Feb. 14). ...